A contemporary prostate cancer grading system: a validated alternative to the Gleason score JI Epstein, MJ Zelefsky, DD Sjoberg, JB Nelson, L Egevad, ... European urology 69 (3), 428-435, 2016 | 1663 | 2016 |
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience M Han, AW Partin, CR Pound, JI Epstein, PC Walsh Urologic Clinics of North America 28 (3), 555-565, 2001 | 1349 | 2001 |
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer R Hu, TA Dunn, S Wei, S Isharwal, RW Veltri, E Humphreys, M Han, ... Cancer research 69 (1), 16-22, 2009 | 1330 | 2009 |
Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results KA Roehl, M Han, CG Ramos, JAV Antenor, WJ Catalona The Journal of urology 172 (3), 910-914, 2004 | 1103 | 2004 |
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer M Han, AW Partin, M Zahurak, S Piantadosi, JI Epstein, PC Walsh The Journal of urology 169 (2), 517-523, 2003 | 1002 | 2003 |
Prostate cancer–specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy BJ Trock, M Han, SJ Freedland, EB Humphreys, TL DeWeese, AW Partin, ... Jama 299 (23), 2760-2769, 2008 | 791 | 2008 |
Predicting 15-year prostate cancer specific mortality after radical prostatectomy SE Eggener, PT Scardino, PC Walsh, M Han, AW Partin, BJ Trock, Z Feng, ... The Journal of urology 185 (3), 869-875, 2011 | 776 | 2011 |
Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies SD Kundu, KA Roehl, SE Eggener, JAV Antenor, M Han, WJ Catalona The Journal of urology 172 (6 Part 1), 2227-2231, 2004 | 721 | 2004 |
Prostate specific antigen best practice statement: 2009 update KL Greene, PC Albertsen, RJ Babaian, HB Carter, PH Gann, M Han, ... The Journal of urology 189 (1), S2-S11, 2013 | 719 | 2013 |
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011 JB Eifler, Z Feng, BM Lin, MT Partin, EB Humphreys, M Han, JI Epstein, ... BJU international 111 (1), 2013 | 492 | 2013 |
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients TL Lotan, B Gurel, S Sutcliffe, D Esopi, W Liu, J Xu, JL Hicks, BH Park, ... Clinical cancer research 17 (20), 6563-6573, 2011 | 398 | 2011 |
Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death R Na, SL Zheng, M Han, H Yu, D Jiang, S Shah, CM Ewing, L Zhang, ... European urology 71 (5), 740-747, 2017 | 388 | 2017 |
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer M Han, AW Partin, S Piantadosi, JI Epstein, PC Walsh The Journal of urology 166 (2), 416-419, 2001 | 350 | 2001 |
Characteristics of prostate cancer detected by digital rectal examination only OT Okotie, KA Roehl, M Han, S Loeb, SN Gashti, WJ Catalona Urology 70 (6), 1117-1120, 2007 | 310 | 2007 |
Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate-and high-risk men AE Ross, MH Johnson, K Yousefi, E Davicioni, GJ Netto, L Marchionni, ... European urology 69 (1), 157-165, 2016 | 269 | 2016 |
The role of anxiety in prostate carcinoma: a structured review of the literature W Dale, P Bilir, M Han, D Meltzer Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 266 | 2005 |
African American men with very low–risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? D Sundi, AE Ross, EB Humphreys, M Han, AW Partin, HB Carter, ... Journal of clinical oncology 31 (24), 2991-2997, 2013 | 262 | 2013 |
Radiofrequency lumbar facet denervation: analysis of prognostic factors RB North, M Han, M Zahurak, DH Kidd Pain 57 (1), 77-83, 1994 | 255 | 1994 |
18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer SP Rowe, KL Gage, SF Faraj, KJ Macura, TC Cornish, ... Journal of Nuclear Medicine 56 (7), 1003-1010, 2015 | 236 | 2015 |
The natural history and treatment of adrenal myelolipoma M Han, AL Burnett, EK Fishman, FF Marshall The Journal of urology 157 (4), 1213-1216, 1997 | 219 | 1997 |